EP0025783A4 - Composition pharmaceutique pour utilisation dans la reduction du taux du cholesterol. - Google Patents

Composition pharmaceutique pour utilisation dans la reduction du taux du cholesterol.

Info

Publication number
EP0025783A4
EP0025783A4 EP19790901432 EP79901432A EP0025783A4 EP 0025783 A4 EP0025783 A4 EP 0025783A4 EP 19790901432 EP19790901432 EP 19790901432 EP 79901432 A EP79901432 A EP 79901432A EP 0025783 A4 EP0025783 A4 EP 0025783A4
Authority
EP
European Patent Office
Prior art keywords
pharmaceutical composition
cholesterol levels
serum cholesterol
reducing serum
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP19790901432
Other languages
German (de)
English (en)
Other versions
EP0025783A1 (fr
Inventor
Fritz W Zilliken
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Z-L LP
Z L LP
Original Assignee
Z-L LP
Z L LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Z-L LP, Z L LP filed Critical Z-L LP
Publication of EP0025783A1 publication Critical patent/EP0025783A1/fr
Publication of EP0025783A4 publication Critical patent/EP0025783A4/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
    • C09K15/04—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds
    • C09K15/06—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing oxygen
    • C09K15/08—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing oxygen containing a phenol or quinone moiety
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00—Preserving by using additives, e.g. anti-oxidants
    • C11B5/0021—Preserving by using additives, e.g. anti-oxidants containing oxygen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/06—Hydroxylating

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP19790901432 1979-03-19 1980-10-08 Composition pharmaceutique pour utilisation dans la reduction du taux du cholesterol. Ceased EP0025783A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/022,202 US4234577A (en) 1979-03-19 1979-03-19 Ergostadientriols, compositions containing same, and methods of preparing and using same
US22202 1979-03-19

Publications (2)

Publication Number Publication Date
EP0025783A1 EP0025783A1 (fr) 1981-04-01
EP0025783A4 true EP0025783A4 (fr) 1981-10-27

Family

ID=21808357

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19790901432 Ceased EP0025783A4 (fr) 1979-03-19 1980-10-08 Composition pharmaceutique pour utilisation dans la reduction du taux du cholesterol.

Country Status (6)

Country Link
US (1) US4234577A (fr)
EP (1) EP0025783A4 (fr)
JP (1) JPS56500336A (fr)
DK (1) DK492880A (fr)
NL (1) NL7906287A (fr)
WO (1) WO1980002027A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8626344D0 (en) * 1986-11-04 1986-12-03 Zyma Sa Bicyclic compounds
DE4000397A1 (de) * 1990-01-09 1991-07-11 Hoechst Ag Lipidselektive antioxidantien sowie deren herstellung und verwendung
FR2731706B1 (fr) 1995-03-14 1997-04-11 Cird Galderma Composes heterocycliques aromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
AUPQ008299A0 (en) * 1999-04-30 1999-05-27 G.J. Consultants Pty Ltd Isoflavone metabolites
WO2002088308A2 (fr) 2001-04-26 2002-11-07 Archer-Daniels-Midland Company Nouvelles souches de rhizopus oryzae et leurs utilisations
KR20050044466A (ko) * 2001-11-15 2005-05-12 다카사고 고료 고교 가부시키가이샤 열화 방지제 및 이를 포함하는 제품
US7524526B2 (en) * 2002-04-10 2009-04-28 Archer-Daniels-Midland Company Process for producing high purity isoflavones
RU2377781C2 (ru) 2003-07-17 2010-01-10 Юнилевер Н.В. Способ приготовления пищевой дисперсии, содержащей масло и структурирующий агент
US20050175745A1 (en) * 2004-02-06 2005-08-11 Jerzy Zawistowski Method of preservation of a food prodcut and composition comprising one or more phytosterols and/or phytostanols useful for this purpose
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
WO2006032085A1 (fr) 2004-09-21 2006-03-30 Novogen Research Pty Ltd Dérivés de chromane substitués, médicaments et utilisation à des fins thérapeutiques
EP1885192B8 (fr) 2005-02-17 2015-05-13 Unilever N.V. Granules comprenant des sterols
US8486899B2 (en) * 2008-11-19 2013-07-16 Morinaga Milk Industry Co., Ltd. Antioxidant
ES2467990T3 (es) 2010-06-22 2014-06-13 Unilever Nv Polvos de grasa comestible
ES2773753T3 (es) 2010-11-01 2020-07-14 Mei Pharma Inc Compuestos isoflavonoides y métodos para el tratamiento del cáncer
WO2012079955A1 (fr) 2010-12-17 2012-06-21 Unilever Nv Processus de compactage d'une poudre de graisse microporeuse et poudre de graisse compactée ainsi obtenue
US9119405B2 (en) 2010-12-22 2015-09-01 Conopco, Inc. Water-in-oil emulsion comprising omega-3 fatty acids and process for the manufacture of same
ITMI20110545A1 (it) 2011-04-04 2012-10-05 Lundbeck Pharmaceuticals Italy S P A Metodo per la preparazione di intermedi di processo per la sintesi di argatroban monoidrato
EP3253208B1 (fr) 2015-02-02 2021-05-05 MEI Pharma, Inc. Polythérapies pour son utilisation dans le traitement du cancer du sein

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1810M (fr) * 1960-11-17 1963-05-13 Takeda Chemical Industries Ltd Perfectionnements apportés a la thérapie des maladies du type de l'athérosclérose et a la lutte contre ces maladies.
FR7466M (fr) * 1968-06-28 1969-11-24

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1553222A (en) * 1975-05-07 1979-09-26 Steele Chemical Co Ltd 14 - hydroxy 3- eoxycardenolides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1810M (fr) * 1960-11-17 1963-05-13 Takeda Chemical Industries Ltd Perfectionnements apportés a la thérapie des maladies du type de l'athérosclérose et a la lutte contre ces maladies.
FR7466M (fr) * 1968-06-28 1969-11-24

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8002027A1 *

Also Published As

Publication number Publication date
DK492880A (da) 1980-11-19
US4234577A (en) 1980-11-18
JPS56500336A (fr) 1981-03-19
WO1980002027A1 (fr) 1980-10-02
NL7906287A (nl) 1980-09-23
EP0025783A1 (fr) 1981-04-01

Similar Documents

Publication Publication Date Title
EP0025783A4 (fr) Composition pharmaceutique pour utilisation dans la reduction du taux du cholesterol.
AU515341B2 (en) Pharmaceutical composition
AU5717980A (en) Photopolymerizable composition
MY8500051A (en) Novel 1-aryl-2-acylamido-3-fluoro-1-propanols, theiri preparation and pharmaceutical composition containing them
GB2141633B (en) Carbonator
AU530506B2 (en) Weighing and dispensing unit
AU499187B2 (en) Improvements in or relating in radiography
GB2061887B (en) Delivering sheets
JPS55164626A (en) Corticosteroid composition
AU529400B2 (en) Dispenser
JPS5598110A (en) Local administration composition
DE2862210D1 (en) Dispersions in particulate form, a process for making the dispersions and pharmaceutical compositions containing them
IL56839A0 (en) Improvement in specific binding assay technique
GB2055397B (en) Rotating biological film contactor
GB2048671B (en) Pharmaceutical composition containing dihydroegotoxine
DE3071391D1 (en) 2-hydroxyaclacinomycin a, pharmaceutical composition containing it; 2-hydroxyaclavinone and fermentative process for preparing same
ZA806383B (en) Long acting pharmaceutical composition
AU2519677A (en) Pharmaceutical Composition
AU5473580A (en) Dispenser
AU513948B2 (en) Hexahydro-trans-pyridoindole neuroleptic agents
JPS5694267A (en) Highly coagulating*active antibody serum
AU562525B2 (en) Antifungal pharmaceutical composition
DE3264768D1 (en) Novel heptadecapeptide, a method for its preparation and a pharmaceutical composition containing the same
GB2049416B (en) Pharmaceutical composition
PH19323A (en) Magnfication changing for use in duplicators

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): AT CH DE FR GB LU SE

17P Request for examination filed

Effective date: 19810331

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19841123

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ZILLIKEN, FRITZ W.